Subgenomic replicons of yellow fever virus (YFV) were constructed to allow expression of heterologous reporter genes in a replication-dependent manner. Expression of the antibiotic resistance gene neomycin phosphotransferase II (Neo) from one of these YFV replicons allowed selection of a stable population of cells (BHK-REP cells) in which the YFV replicon persistently replicated. BHK-REP cells were successfully used to trans-complement replication-defective YFV replicons harboring large internal deletions within either the NS1 or NS3 proteins. Although replicons with large deletions in either NS1 or NS3 were trans-complemented in BHK-REP, replicons that contained deletions of NS3 were trans-complemented at lower levels. In addition, replicons that retained the N-terminal protease domain of NS3 in cis were trans-complemented with higher efficiency than replicons in which both the protease and helicase domains of NS3 were deleted. To study packaging of YFV replicons, Sindbis replicons were constructed that expressed the YFV structural proteins in trans. Using these Sindbis replicons, both replication-competent and trans-complemented, replication-defective YFV replicons could be packaged into pseudo-infectious particles (PIPs). Although these results eliminate a potential role of either NS1 or full-length NS3 in cis for packaging and assembly of the flavivirus virion, they do not preclude the possibility that these proteins may act in trans during these processes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.virol.2004.10.034 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel Pyrazino[1,2-]indole-1,3(2,4)-dione Derivatives Targeting the Replication of Viruses: Structural and Mechanistic Insights.
Viruses
August 2024
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, GR-15771 Athens, Greece.
Infections with viruses, such as hepatitis C (HCV), dengue (DENV), and yellow fever (YFV) viruses, are major public health problems worldwide. In the case of HCV, treatment is associated with drug resistance and high costs, while there is no clinically approved therapy for DENV and YFV. Consequently, there is still a need for new chemotherapies with alternative modes of action.
View Article and Find Full Text PDFSpecialized -Acting RNA Elements Balance Genome Cyclization to Ensure Efficient Replication of Yellow Fever Virus.
J Virol
April 2023
The Centre for Infection and Immunity Studies, School of Medicine, Sun Yat-sen University, Shenzhen, Guangdong, China.
Genome cyclization is essential for viral RNA (vRNA) replication of the vertebrate-infecting flaviviruses, and yet its regulatory mechanisms are not fully understood. Yellow fever virus (YFV) is a notorious pathogenic flavivirus. Here, we demonstrated that a group of -acting RNA elements in YFV balance genome cyclization to govern efficient vRNA replication.
View Article and Find Full Text PDFEstablishment of Vero cell lines persistently harboring a yellow fever virus 17D subgenomic replicon.
Virus Res
December 2022
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan; Department of Quality Assurance, Radiation Safety, and Information System, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Article Synopsis
- Yellow fever virus (YFV) causes yellow fever, an acute viral hemorrhagic disease, and while vaccines exist, there are no specific antiviral drugs, making research on new treatments important.
- Researchers established Vero cell lines that persistently harbor a YFV subgenomic replicon, which allows for the screening of antiviral agents targeting YFV replication and provides a marker for ongoing viral replication.
- They tested five antiviral agents and found that all, except rifapentine, reduced both GFP fluorescence (indicating viral replication) and viral RNA levels in the replicon cells, demonstrating potential pathways for new antiviral drug development.
A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of Inhibits Replication of Hepatitis C Virus and Other Flavivirids.
Viruses
July 2022
MRC-University of Glasgow Centre for Virus Research, 464 Bearsden Rd, Bearsden, Glasgow G61 1QH, UK.
Natural hepatitis C virus (HCV) infection is restricted to humans, whereas other primates such as rhesus macaques are non-permissive for infection. To identify human and rhesus macaque genes that differ or share the ability to inhibit HCV replication, we conducted a medium-throughput screen of lentivirus-expressed host genes that disrupt replication of HCV subgenomic replicon RNA expressing secreted Gaussia luciferase. A combined total of >800 interferon-stimulated genes (ISGs) were screened.
View Article and Find Full Text PDFRifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
Emerg Microbes Infect
December 2022
Department of Microbiology, Faculty of Naval Medicine, Naval Medical University, Shanghai, People's Republic of China.
Yellow fever virus (YFV) infection is a major public concern that threatens a large population in South America and Africa. No specific anti-YFV drugs are available till now. Here, we report that rifapentine is a potent YFV inhibitor in various cell lines by high-throughput drugs screening, acting at both cell entry and replication steps.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!